Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Cidara Therapeutics, Inc. (CDTX) had Receiveable Turnover of 0.75 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.27M |
|
$-169.83M |
|
-- |
|
$1.27M |
|
$177.38M |
|
$-176.10M |
|
$5.81M |
|
$-170.29M |
|
$-170.29M |
|
$-170.29M |
|
$-170.29M |
|
$-169.83M |
|
$-170.29M |
|
$-176.10M |
|
$-175.69M |
|
6.35M |
|
6.35M |
|
$-26.75 |
|
$-26.75 |
|
| Balance Sheet Financials | |
$210.74M |
|
$0.52M |
|
$4.06M |
|
$214.80M |
|
$49.55M |
|
-- |
|
$1.93M |
|
$51.49M |
|
$163.31M |
|
$163.31M |
|
$163.31M |
|
10.95M |
|
| Cash Flow Statement Financials | |
$-176.53M |
|
$-0.13M |
|
$337.06M |
|
$35.78M |
|
$196.18M |
|
$160.40M |
|
$3.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.25 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
100.00% |
|
-13811.92% |
|
-13811.92% |
|
-13779.22% |
|
-13356.16% |
|
-13319.76% |
|
$-176.66M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
|
Receiveable Turnover |
0.75 |
484.95 |
|
-104.28% |
|
-104.28% |
|
-79.28% |
|
-104.28% |
|
$14.92 |
|
$-27.82 |
|
$-27.80 |
|